Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-5-2
pubmed:abstractText
Chemotherapy-induced peripheral neuropathy (CIPN) is a troublesome chronic symptom that has no proven pharmacologic treatment. The purpose of this double-blind randomized placebo-controlled trial was to evaluate a novel compounded topical gel for this problem.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1433-7339
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
833-41
pubmed:meshHeading
pubmed-meshheading:20496177-Administration, Cutaneous, pubmed-meshheading:20496177-Adrenergic Uptake Inhibitors, pubmed-meshheading:20496177-Aged, pubmed-meshheading:20496177-Amitriptyline, pubmed-meshheading:20496177-Antineoplastic Agents, pubmed-meshheading:20496177-Baclofen, pubmed-meshheading:20496177-Double-Blind Method, pubmed-meshheading:20496177-Drug Combinations, pubmed-meshheading:20496177-Excitatory Amino Acid Antagonists, pubmed-meshheading:20496177-Female, pubmed-meshheading:20496177-GABA-B Receptor Agonists, pubmed-meshheading:20496177-Gels, pubmed-meshheading:20496177-Humans, pubmed-meshheading:20496177-Ketamine, pubmed-meshheading:20496177-Lecithins, pubmed-meshheading:20496177-Male, pubmed-meshheading:20496177-Middle Aged, pubmed-meshheading:20496177-Peripheral Nervous System Diseases, pubmed-meshheading:20496177-Poloxamer, pubmed-meshheading:20496177-Treatment Outcome
pubmed:year
2011
pubmed:articleTitle
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
pubmed:affiliation
Mayo Clinic College of Medicine, 200 First Street, SW, Rochester, MN 55905, USA. Barton.debra@mayo.edu
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural